Patients with metabolic liver diseases may benefit from supplements of a common gut bacterium, a small study suggests.
Why addressing how our brain and our gut talk to each other matter for IBS
19 Feb 2024by Premysl Bercik, Andreu Prados
While the idea that our gut can influence our brain is not new, this is a rapidly growing area of research. Find out more on how gut microbes influence anxiety and stress and why tackling these psychological traits matters for irritable bowel syndrome.
Gut microbiota’s impact: linking neonatal jaundice and IBD through bilirubin processing
7 Feb 2024by Manon Oliero
The low amount of bacteria from the gut microbiota able to process bilirubin, a product of heme degradation, during the neonatal period of life suggests a strong connection between the microbiome composition and development of jaundice in infants. In other words, the lack of certain bacteria in the gut of infants seems to be linked to the risk of developing jaundice.
“In the future, we could treat microbiota to reduce the risk of pancreatic cancer development”
11 Jan 2024by Cristina Sáez
In this interview, Dr. Núria Malats from the Spanish National Cancer Research Centre (CNIO) shares promising advances regarding the relationship between gut microbiota and pancreatic cancer, unveiling exciting possibilities for early detection and personalized treatment.
Reduced red meat intake and gut microbial metabolite indole-3-acetate linked to better insulin resistance after gastric bypass, new study finds
8 Jan 2024by Joël Doré, Andreu Prados
The gut microbiome has been involved in reducing adiposity in patients with obesity after gastric bypass. New research suggests that food intake, tryptophan metabolism, and gut microbiota composition can explain the glycemic improvement observed in patients after Roux-en-Y gastric bypass.
Diets for irritable bowel syndrome: what you need to know
20 Dec 2023by Andreu Prados, Kate Scarlata
Food is considered the main trigger of digestive symptoms in the vast majority of patients living with IBS. While finding foods that do not prompt gastrointestinal (GI) symptoms has been a challenge for many people with IBS, restrictive diets can come with potential risks. Learn more about diets with evidence in IBS.
Protist Tritrichomonas arnold protects against viral-induced gluten intolerance
18 Dec 2023by Heather Galipeau, Mark Wulczynski
Celiac disease is a chronic immune-mediated enteropathy that may be unleashed by enteric viral infections. However, new findings in mice identified a commensal protist, Tritrichomonas arnold, that protects against reovirus-induced intolerance to gluten by counteracting virus-induced proinflammatory dendritic cell activation.
Where are we on microbiome-based therapies in disorders of gut-brain interaction?
4 Dec 2023by Andreu Prados, Rene van den Wijngaard
NeuroGASTRO 2023, the leading meeting in Europe held by ESNM on the latest developments in neurogastroenterology, digestive motility, and disorders of gut-brain interaction, took place from August 31st to September 2nd, 2023. Find out more about the main takeaways from the role of fecal microbiota transplants, microbial consortia and probiotics in disorders of gut-brain interaction picked up by GMFH editors (Part 2).
Osteomicrobiology reveals a promising link between gut microbiota and osteoporosis prevention. New research highlights microbial strains influencing bone density, paving the way for targeted therapies. Further investigations will clarify this gut-bone axis and its potential in skeletal health.
What lies beneath a dirty diaper? (Spoiler: thousands of unknown allied viruses!)
15 Nov 2023by Cristina Sáez
An international team of scientists has studied diaper samples of nearly 650 healthy 1-year-old babies for 5 years and has discovered 10,000 species of viruses, most of them unknown until now. Far from causing children to be sick, those viruses are thought to be true allies, playing an important role in protecting us from chronic diseases.